체험은 만족하셨나요?
방금 푼 그 흐름,
합격까지 이어보세요
지식 자료를 소장하고 멋진 의료인으로 성장하세요
학습 자료 둘러보기 →| Intervention | Rationale & Priority Analysis |
|---|---|
| 1. Encourage increased fluid intake to 3-4 liters per day | Increased water intake suppresses vasopressin, a hormone that promotes cyst growth. This is a key disease-modifying strategy recommended in the guidelines [1]. However, its effect is long-term and supportive; it does not directly prevent an imminent hypertensive crisis or stroke. |
| 2. Administer prescribed analgesics for pain management | Flank pain is a common symptom from cyst expansion, hemorrhage, or infection. Pain management is essential for comfort but addresses a symptom, not the most serious systemic complication. An acute change in pain character could signal cyst rupture or infection, requiring further assessment, but routine analgesia is not the top safety priority. |
| 3. Monitor blood pressure closely and implement hypertension management | This is the correct priority. Given the direct link between hypertension and both accelerated renal decline and catastrophic events like intracranial aneurysm rupture, meticulous BP monitoring and adherence to a strict target (often lower than the general population) is the most critical nursing action to prevent the most serious complication [1]. |
| 4. Provide dietary education about protein restriction | Dietary modification is important as kidney function declines. However, in early ADPKD with preserved renal function, aggressive protein restriction is not the primary intervention and does not take precedence over cardiovascular risk reduction. The focus is on sodium restriction to support blood pressure control. |
In autosomal dominant polycystic kidney disease (ADPKD), the priority is preventing catastrophic vascular events. The 2025 KDIGO guideline update emphasizes that strict blood pressure control is the cornerstone of care to slow disease progression and prevent cardiovascular complications.
While pain management and fluid intake are supportive measures, they do not mitigate the immediate, life-threatening risk of aneurysm rupture or heart failure. All interventions must be framed within the context of strict cardiovascular risk reduction.
학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요.